Cassandra Slader Selected Research

Breast Neoplasms (Breast Cancer)

1/2021

A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cassandra Slader Research Topics

Disease

2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2013 - 06/2012
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Exanthema (Rash) 01/2021
1	Hyperglycemia 01/2021
1	Hypokalemia 01/2021
1	Disease Progression 01/2021
1	Residual Neoplasm 07/2013

Drug/Important Bio-Agent (IBA)

2	Imatinib Mesylate (Gleevec)FDA Link 07/2013 - 06/2012
1	Alanine Transaminase (SGPT)IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Tamoxifen FDA LinkGeneric 01/2021
1	NVP-BKM120IBA 01/2021
1	AlpelisibIBA 01/2021
1	Goserelin (Zoladex)FDA Link 01/2021
1	Organic Cation Transporter 1IBA 06/2012
1	Proteins (Proteins, Gene)FDA Link 06/2012

Therapy/Procedure

1	Terminal Care (Care, Terminal) 01/2021
1	Therapeutics 06/2012